ReviewTranslational oncology2026

PD-1/PD-L1 immune checkpoint inhibitors in Hodgkin lymphoma: A meta- and network meta-analysis.

Tingxi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.